Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katia Varani

Showing results (121-130 of 239) with videos related to

Pageof 24
Sort By:
Clinical and Experimental Nephrology|June 10, 2016
Double inhibition of cAMP and mTOR signalling may potentiate the reduction of cell growth in ADPKD cellsLucia de Stephanis, Anna Bonon, Katia Varani, et al.
Plos One|January 18, 2013
A(2A) adenosine receptors are differentially modulated by pharmacological treatments in rheumatoid arthritis patients and their stimulation ameliorates adjuvant-induced arthritis in ratsFabrizio Vincenzi, Melissa Padovan, Martina Targa, et al.
European Journal of Immunology|May 11, 2013
Multiple sclerosis lymphocytes upregulate A2A adenosine receptors that are antiinflammatory when stimulatedFabrizio Vincenzi, Carmen Corciulo, Martina Targa, et al.
Frontiers in Pharmacology|December 19, 2017
Inhibition of A<sub>2A</sub> Adenosine Receptor Signaling in Cancer Cells Proliferation by the Novel Antagonist TP455Stefania Gessi, Serena Bencivenni, Enrica Battistello, et al.
European Journal of Medicinal Chemistry|May 17, 2003
Recent developments in the field of A2A and A3 adenosine receptor antagonistsPier Giovanni Baraldi, Mojgan Aghazadeh Tabrizi, Andrea Bovero, et al.
Biomolecules|June 28, 2023
Caffeine for Prevention of Alzheimer's Disease: Is the A<sub>2A</sub> Adenosine Receptor Its Target?Stefania Merighi, Alessia Travagli, Manuela Nigro, et al.
International Journal of Molecular Sciences|March 25, 2017
Role and Function of A<sub>2A</sub> and A₃ Adenosine Receptors in Patients with Ankylosing Spondylitis, Psoriatic Arthritis and Rheumatoid ArthritisAnnalisa Ravani, Fabrizio Vincenzi, Alessandra Bortoluzzi, et al.
Biomolecules|September 28, 2023
Pharmacology of Adenosine Receptors: Recent AdvancementsFabrizio Vincenzi, Silvia Pasquini, Chiara Contri, et al.
International Journal of Molecular Sciences|January 8, 2020
"<i>Bridging the Gap</i>" Everything that Could Have Been Avoided If We Had Applied Gender Medicine, Pharmacogenetics and Personalized Medicine in the Gender-Omics and Sex-Omics EraDonato Gemmati, Katia Varani, Barbara Bramanti, et al.
Bioconjugate Chemistry|November 20, 2003
Asymmetrical nitrido tc-99m heterocomplexes as potential imaging agents for benzodiazepine receptorsAlessandra Boschi, Licia Uccelli, Adriano Duatti, et al.
Pageof 24

Showing results (121-130 of 239) with videos related to

Sort By:
Pageof 24
Clinical and Experimental Nephrology|June 10, 2016
Double inhibition of cAMP and mTOR signalling may potentiate the reduction of cell growth in ADPKD cellsLucia de Stephanis, Anna Bonon, Katia Varani, et al.
Plos One|January 18, 2013
A(2A) adenosine receptors are differentially modulated by pharmacological treatments in rheumatoid arthritis patients and their stimulation ameliorates adjuvant-induced arthritis in ratsFabrizio Vincenzi, Melissa Padovan, Martina Targa, et al.
European Journal of Immunology|May 11, 2013
Multiple sclerosis lymphocytes upregulate A2A adenosine receptors that are antiinflammatory when stimulatedFabrizio Vincenzi, Carmen Corciulo, Martina Targa, et al.
Frontiers in Pharmacology|December 19, 2017
Inhibition of A<sub>2A</sub> Adenosine Receptor Signaling in Cancer Cells Proliferation by the Novel Antagonist TP455Stefania Gessi, Serena Bencivenni, Enrica Battistello, et al.
European Journal of Medicinal Chemistry|May 17, 2003
Recent developments in the field of A2A and A3 adenosine receptor antagonistsPier Giovanni Baraldi, Mojgan Aghazadeh Tabrizi, Andrea Bovero, et al.
Biomolecules|June 28, 2023
Caffeine for Prevention of Alzheimer's Disease: Is the A<sub>2A</sub> Adenosine Receptor Its Target?Stefania Merighi, Alessia Travagli, Manuela Nigro, et al.
International Journal of Molecular Sciences|March 25, 2017
Role and Function of A<sub>2A</sub> and A₃ Adenosine Receptors in Patients with Ankylosing Spondylitis, Psoriatic Arthritis and Rheumatoid ArthritisAnnalisa Ravani, Fabrizio Vincenzi, Alessandra Bortoluzzi, et al.
Biomolecules|September 28, 2023
Pharmacology of Adenosine Receptors: Recent AdvancementsFabrizio Vincenzi, Silvia Pasquini, Chiara Contri, et al.
International Journal of Molecular Sciences|January 8, 2020
"<i>Bridging the Gap</i>" Everything that Could Have Been Avoided If We Had Applied Gender Medicine, Pharmacogenetics and Personalized Medicine in the Gender-Omics and Sex-Omics EraDonato Gemmati, Katia Varani, Barbara Bramanti, et al.
Bioconjugate Chemistry|November 20, 2003
Asymmetrical nitrido tc-99m heterocomplexes as potential imaging agents for benzodiazepine receptorsAlessandra Boschi, Licia Uccelli, Adriano Duatti, et al.
Pageof 24